Clinical Trial Update: Evaluation of DHA for the Treatment of PSC [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating docosahexaenoic acid (DHA) for primary sclerosing cholangitis, with colitis as a related condition, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colitis
• Sclerosing Cholangitis

Drugs mentioned

• DHA (docosahexaenoic acid) (docosahexaenoic acid)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Primary Sclerosing Cholangitis, Colitis | Phase 1 | Status: COMPLETED